Action plan for determining and monitoring the prevalence of chronic kidney disease

Josef Coresh, Jiun Ruey Hu, Aminu K. Bello, Harold I. Feldman, Agnes B. Fogo, Mohammad Reza Ganji, David C. Harris, Andrew S. Levey, Ikechi G. Okpechi, Benedicte Stengel, Bernadette Thomas, Andrzej Wiecek, Ron T. Gansevoort

Research output: Contribution to journalReview article

Abstract

Chronic kidney disease (CKD) continues to remain high globally, up to 13.4% by one estimate. Although the number, geographic distribution, size, and quality of the studies examining CKD prevalence and incidence have increased over the past decade, the global capacity for CKD surveillance is still far less developed than that for hypertension, diabetes, and cardiovascular disease. Estimating CKD prevalence is constrained by inadequate standardization of serum creatinine and urine albumin assays, heterogeneity in study designs, lack of national registries in many countries, incomplete adoption of disease classification guidelines, and inconsistent use of evidence-based equations for estimating glomerular filtration rate. Goal 1: Improve monitoring of CKD prevalence. To achieve this, disseminate the rationale for CKD prevalence monitoring, achieve uniform measurement of CKD markers, promote inclusion of CKD measurements in all large chronic disease cohorts and health surveys, harness administrative claims data for CKD surveillance, and incorporate the new CKD classification system in the International Classification of Diseases. Goal 2: Improve CKD monitoring of populations underrepresented in studies to date. To achieve this, establish registries of chronic dialysis and transplantation in all countries; establish registries for special CKD groups, such as children, patients with rare diseases, and patients with special etiologies of CKD. Goal 3: Improve identification of individuals with CKD. To achieve this, implement the Kidney Disease: Improving Global Outcomes guidelines for screening and testing, carry out randomized studies on screening strategies, ensure that estimated glomerular filtration rate is reported with all reports of serum creatinine, and leverage new software for identification and follow-up of CKD cases.

Original languageEnglish (US)
Pages (from-to)63-70
Number of pages8
JournalKidney International Supplements
Volume7
Issue number2
DOIs
StatePublished - Oct 1 2017

Fingerprint

Chronic Renal Insufficiency
Registries
Glomerular Filtration Rate
Creatinine
Guidelines
Kidney Diseases
International Classification of Diseases
Rare Diseases
Health Surveys
Serum
Dialysis
Albumins
Chronic Disease
Cardiovascular Diseases
Software
Transplantation

Keywords

  • chronic kidney disease
  • glomerular filtration rate
  • monitoring
  • prevalence
  • standardization

ASJC Scopus subject areas

  • Nephrology

Cite this

Coresh, J., Hu, J. R., Bello, A. K., Feldman, H. I., Fogo, A. B., Ganji, M. R., ... Gansevoort, R. T. (2017). Action plan for determining and monitoring the prevalence of chronic kidney disease. Kidney International Supplements, 7(2), 63-70. https://doi.org/10.1016/j.kisu.2017.07.002

Action plan for determining and monitoring the prevalence of chronic kidney disease. / Coresh, Josef; Hu, Jiun Ruey; Bello, Aminu K.; Feldman, Harold I.; Fogo, Agnes B.; Ganji, Mohammad Reza; Harris, David C.; Levey, Andrew S.; Okpechi, Ikechi G.; Stengel, Benedicte; Thomas, Bernadette; Wiecek, Andrzej; Gansevoort, Ron T.

In: Kidney International Supplements, Vol. 7, No. 2, 01.10.2017, p. 63-70.

Research output: Contribution to journalReview article

Coresh, J, Hu, JR, Bello, AK, Feldman, HI, Fogo, AB, Ganji, MR, Harris, DC, Levey, AS, Okpechi, IG, Stengel, B, Thomas, B, Wiecek, A & Gansevoort, RT 2017, 'Action plan for determining and monitoring the prevalence of chronic kidney disease', Kidney International Supplements, vol. 7, no. 2, pp. 63-70. https://doi.org/10.1016/j.kisu.2017.07.002
Coresh, Josef ; Hu, Jiun Ruey ; Bello, Aminu K. ; Feldman, Harold I. ; Fogo, Agnes B. ; Ganji, Mohammad Reza ; Harris, David C. ; Levey, Andrew S. ; Okpechi, Ikechi G. ; Stengel, Benedicte ; Thomas, Bernadette ; Wiecek, Andrzej ; Gansevoort, Ron T. / Action plan for determining and monitoring the prevalence of chronic kidney disease. In: Kidney International Supplements. 2017 ; Vol. 7, No. 2. pp. 63-70.
@article{f656f2a8c9d347beac5c2cbd8e9d091d,
title = "Action plan for determining and monitoring the prevalence of chronic kidney disease",
abstract = "Chronic kidney disease (CKD) continues to remain high globally, up to 13.4{\%} by one estimate. Although the number, geographic distribution, size, and quality of the studies examining CKD prevalence and incidence have increased over the past decade, the global capacity for CKD surveillance is still far less developed than that for hypertension, diabetes, and cardiovascular disease. Estimating CKD prevalence is constrained by inadequate standardization of serum creatinine and urine albumin assays, heterogeneity in study designs, lack of national registries in many countries, incomplete adoption of disease classification guidelines, and inconsistent use of evidence-based equations for estimating glomerular filtration rate. Goal 1: Improve monitoring of CKD prevalence. To achieve this, disseminate the rationale for CKD prevalence monitoring, achieve uniform measurement of CKD markers, promote inclusion of CKD measurements in all large chronic disease cohorts and health surveys, harness administrative claims data for CKD surveillance, and incorporate the new CKD classification system in the International Classification of Diseases. Goal 2: Improve CKD monitoring of populations underrepresented in studies to date. To achieve this, establish registries of chronic dialysis and transplantation in all countries; establish registries for special CKD groups, such as children, patients with rare diseases, and patients with special etiologies of CKD. Goal 3: Improve identification of individuals with CKD. To achieve this, implement the Kidney Disease: Improving Global Outcomes guidelines for screening and testing, carry out randomized studies on screening strategies, ensure that estimated glomerular filtration rate is reported with all reports of serum creatinine, and leverage new software for identification and follow-up of CKD cases.",
keywords = "chronic kidney disease, glomerular filtration rate, monitoring, prevalence, standardization",
author = "Josef Coresh and Hu, {Jiun Ruey} and Bello, {Aminu K.} and Feldman, {Harold I.} and Fogo, {Agnes B.} and Ganji, {Mohammad Reza} and Harris, {David C.} and Levey, {Andrew S.} and Okpechi, {Ikechi G.} and Benedicte Stengel and Bernadette Thomas and Andrzej Wiecek and Gansevoort, {Ron T.}",
year = "2017",
month = "10",
day = "1",
doi = "10.1016/j.kisu.2017.07.002",
language = "English (US)",
volume = "7",
pages = "63--70",
journal = "Kidney International Supplements",
issn = "2157-1724",
publisher = "Nature Publishing Group",
number = "2",

}

TY - JOUR

T1 - Action plan for determining and monitoring the prevalence of chronic kidney disease

AU - Coresh, Josef

AU - Hu, Jiun Ruey

AU - Bello, Aminu K.

AU - Feldman, Harold I.

AU - Fogo, Agnes B.

AU - Ganji, Mohammad Reza

AU - Harris, David C.

AU - Levey, Andrew S.

AU - Okpechi, Ikechi G.

AU - Stengel, Benedicte

AU - Thomas, Bernadette

AU - Wiecek, Andrzej

AU - Gansevoort, Ron T.

PY - 2017/10/1

Y1 - 2017/10/1

N2 - Chronic kidney disease (CKD) continues to remain high globally, up to 13.4% by one estimate. Although the number, geographic distribution, size, and quality of the studies examining CKD prevalence and incidence have increased over the past decade, the global capacity for CKD surveillance is still far less developed than that for hypertension, diabetes, and cardiovascular disease. Estimating CKD prevalence is constrained by inadequate standardization of serum creatinine and urine albumin assays, heterogeneity in study designs, lack of national registries in many countries, incomplete adoption of disease classification guidelines, and inconsistent use of evidence-based equations for estimating glomerular filtration rate. Goal 1: Improve monitoring of CKD prevalence. To achieve this, disseminate the rationale for CKD prevalence monitoring, achieve uniform measurement of CKD markers, promote inclusion of CKD measurements in all large chronic disease cohorts and health surveys, harness administrative claims data for CKD surveillance, and incorporate the new CKD classification system in the International Classification of Diseases. Goal 2: Improve CKD monitoring of populations underrepresented in studies to date. To achieve this, establish registries of chronic dialysis and transplantation in all countries; establish registries for special CKD groups, such as children, patients with rare diseases, and patients with special etiologies of CKD. Goal 3: Improve identification of individuals with CKD. To achieve this, implement the Kidney Disease: Improving Global Outcomes guidelines for screening and testing, carry out randomized studies on screening strategies, ensure that estimated glomerular filtration rate is reported with all reports of serum creatinine, and leverage new software for identification and follow-up of CKD cases.

AB - Chronic kidney disease (CKD) continues to remain high globally, up to 13.4% by one estimate. Although the number, geographic distribution, size, and quality of the studies examining CKD prevalence and incidence have increased over the past decade, the global capacity for CKD surveillance is still far less developed than that for hypertension, diabetes, and cardiovascular disease. Estimating CKD prevalence is constrained by inadequate standardization of serum creatinine and urine albumin assays, heterogeneity in study designs, lack of national registries in many countries, incomplete adoption of disease classification guidelines, and inconsistent use of evidence-based equations for estimating glomerular filtration rate. Goal 1: Improve monitoring of CKD prevalence. To achieve this, disseminate the rationale for CKD prevalence monitoring, achieve uniform measurement of CKD markers, promote inclusion of CKD measurements in all large chronic disease cohorts and health surveys, harness administrative claims data for CKD surveillance, and incorporate the new CKD classification system in the International Classification of Diseases. Goal 2: Improve CKD monitoring of populations underrepresented in studies to date. To achieve this, establish registries of chronic dialysis and transplantation in all countries; establish registries for special CKD groups, such as children, patients with rare diseases, and patients with special etiologies of CKD. Goal 3: Improve identification of individuals with CKD. To achieve this, implement the Kidney Disease: Improving Global Outcomes guidelines for screening and testing, carry out randomized studies on screening strategies, ensure that estimated glomerular filtration rate is reported with all reports of serum creatinine, and leverage new software for identification and follow-up of CKD cases.

KW - chronic kidney disease

KW - glomerular filtration rate

KW - monitoring

KW - prevalence

KW - standardization

UR - http://www.scopus.com/inward/record.url?scp=85031735183&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85031735183&partnerID=8YFLogxK

U2 - 10.1016/j.kisu.2017.07.002

DO - 10.1016/j.kisu.2017.07.002

M3 - Review article

VL - 7

SP - 63

EP - 70

JO - Kidney International Supplements

JF - Kidney International Supplements

SN - 2157-1724

IS - 2

ER -